Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)

Recruiting now · Phase 2 · Has a placebo group

Conditions studied: CIN 2/3, HPV Infection, Pre-Cancerous Dysplasia, Cervical Dysplasia, HPV Related Disease

In brief

This is a phase II double blind, placebo-controlled, randomized study of Artesunate vaginal inserts for the treatment of women who have cervical high grade intraepithelial neoplasia (CIN2/3).

Key facts

Study ID
NCT04098744
Run by
Frantz Viral Therapeutics, LLC
People needed
78
Starts
2020-09-09
Expected to finish
2026-12-31
Last updated by the study team
2025-10-02

Who can join

Age: 25 and older, up to 100. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.